Next Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2.2M Buy
3,480
+1,006
+41% +$619K 0.14% 152
2021
Q3
$1.5M Sell
2,474
-238
-9% -$148K 0.12% 194
2021
Q2
$1.51M Sell
2,712
-14
-0.5% -$7.09K 0.12% 193
2021
Q1
$1.29M Buy
2,726
+638
+31% +$311K 0.11% 198
2020
Q4
$1.01M Buy
2,088
+722
+53% +$390K 0.1% 215
2020
Q3
$764K Buy
+1,366
New +$828K 0.08% 244
2020
Q2
Sell
-195
Closed -$95K 1610
2020
Q1
$95K Buy
195
+173
+786% +$71.4K 0.01% 772
2019
Q4
$8K Sell
22
-3
-12% -$1.01K ﹤0.01% 1849
2019
Q3
$7K Hold
25
﹤0.01% 1833
2019
Q2
$8K Sell
25
-500
-95% -$166K ﹤0.01% 1760
2019
Q1
$216K Buy
525
+500
+2,000% +$206K 0.05% 341
2018
Q4
$9K Buy
+25
New +$9.15K ﹤0.01% 1385
2017
Q4
Sell
-495
Closed -$219K 1136
2017
Q3
$219K Sell
495
-340
-41% -$162K 0.06% 291
2017
Q2
$410K Sell
835
-81
-9% -$35.4K 0.1% 217
2017
Q1
$356K Buy
916
+21
+2% +$7.78K 0.1% 212
2016
Q4
$329K Buy
895
+535
+149% +$203K 0.06% 338
2016
Q3
$145K Buy
360
+115
+47% +$46.1K 0.03% 557
2016
Q2
$85K Buy
245
+135
+123% +$52K 0.03% 497
2016
Q1
$39K Buy
110
+100
+1,000% +$41.2K 0.01% 699
2015
Q4
$5K Hold
10
﹤0.01% 1389
2015
Q3
$4K Buy
+10
New +$5.37K ﹤0.01% 1493
2014
Q4
Sell
-28
Closed -$10K 2270
2014
Q3
$10K Buy
+28
New +$9.38K ﹤0.01% 1763

Other funds holding REGN

Next Financial Group's REGN Position: Q4 2021 in Review

Next Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q4 2021, buying an estimated $619K and bringing the position to 3,480 shares worth $2.2M. The position accounts for 0.14% of the portfolio, ranked #152.

Next Financial Group first reported a position in REGN in Q3 2014 and has held it in 22 quarters since. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

  • Next Financial Group held 3,480 shares of Regeneron Pharmaceuticals worth $2.2M as of Q4 2021.
  • Next Financial Group bought 1,006 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $619K.
  • Regeneron Pharmaceuticals made up 0.14% of Next Financial Group's portfolio in Q4 2021, its #152 holding.
  • Next Financial Group first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 22 quarters since.
  • 1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.